Redox

WLT Software Announces Elif Eracar as Chief Growth Officer

Retrieved on: 
Monday, January 29, 2024

WLT Software Enterprises, Inc., a developer of custom benefits and claims administration software solutions, has announced Elif Eracar as its new Chief Growth Officer.

Key Points: 
  • WLT Software Enterprises, Inc., a developer of custom benefits and claims administration software solutions, has announced Elif Eracar as its new Chief Growth Officer.
  • She previously served as Chief Operating Officer for TALON, an industry leader in providing groundbreaking healthcare technology solutions.
  • "I am honored to join WLT Software Enterprises as Chief Growth Officer, embarking on a journey to advance healthcare technology and elevate the experiences of patients and providers,” Eracar said.
  • “WLT is so fortunate to have Elif Eracar join the WLT team,” said Shelley Van Etten, President & CEO at WLT Software.

Veteran healthcare executive Trip Hofer joins .406 Ventures as Venture Partner

Retrieved on: 
Wednesday, November 15, 2023

BOSTON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- .406 Ventures , the 18 year-old Boston-based, early-stage venture capital firm focused on healthcare and enterprise technology, added Trip Hofer to its team as a Venture Partner in October.

Key Points: 
  • BOSTON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- .406 Ventures , the 18 year-old Boston-based, early-stage venture capital firm focused on healthcare and enterprise technology, added Trip Hofer to its team as a Venture Partner in October.
  • Hofer brings unparalleled healthcare industry experience to .406.
  • .406 has been investing in disruptive healthcare companies for nearly two decades, backing category-defining companies in primary care, behavioral health, eldercare, and AI-driven healthcare data management.
  • “Working with Trip as an executive leader in our portfolio over the past 20 years has been both fun and successful” said Liam Donohue, Co-founder and Managing Partner of .406 Ventures.

LAIRD SUPERFOOD EXTENDS BRAND WITH NEW ANTIOXIDANT DAILY REDS SUPPLEMENT DRINK

Retrieved on: 
Friday, November 3, 2023

BOULDER, Colo., Nov. 3, 2023 /PRNewswire/ -- Laird Superfood, Inc. (NYSE American: LSF), a leader in functional coffee and creamers and known for its collection of plant-based products with adaptogens, has launched Laird Superfood Antioxidant Daily Reds, providing 2 servings of the daily recommended fruit and vegetable intake in every glass.

Key Points: 
  • BOULDER, Colo., Nov. 3, 2023 /PRNewswire/ -- Laird Superfood , Inc. (NYSE American: LSF), a leader in functional coffee and creamers and known for its collection of plant-based products with adaptogens, has launched Laird Superfood Antioxidant Daily Reds , providing 2 servings of the daily recommended fruit and vegetable intake in every glass.
  • The Antioxidant Daily Reds are a supplement powder that can be mixed into water or blended in a smoothie.
  • In January 2023, the company launched Laird Superfood Prebiotic Daily Greens powdered supplement featuring superfood fruits and vegetables that nourish the gut microbiome.
  • Laird Superfood Antioxidant Daily Reds is launching as a limited time offering this holiday season starting November 3, 2023, in a 14.8-ounce bag at LairdSuperfood.com , and on Amazon at a later date.

Innovative Patient Engagement Technology for Infusion Providers with WeInfuse Partnerships

Retrieved on: 
Tuesday, October 24, 2023

DALLAS, Oct. 24, 2023 /PRNewswire/ -- WeInfuse, a leading software platform for infusion therapy and medication delivery, is renewing its commitment to deliver a comprehensive and best-in-class patient engagement solution for its infusion provider clients by integrating with Formstack and Twilio.

Key Points: 
  • To better serve its infusion provider clients who care for patients suffering from acute illnesses and chronic autoimmune disorders, WeInfuse is launching enhanced patient engagement features powered by Formstack and Twilio.
  • DALLAS, Oct. 24, 2023 /PRNewswire/ -- WeInfuse, a leading software platform for infusion therapy and medication delivery, is renewing its commitment to deliver a comprehensive and best-in-class patient engagement solution for its infusion provider clients by integrating with Formstack and Twilio.
  • To aid providers in maintaining the necessary engagement that is vital to treatment success, WeInfuse is rebuilding its patient engagement feature set from the ground up, powered by Twilio and Formstack.
  • "Our team at WeInfuse has worked tirelessly to bring innovative technology to infusion providers, and the Formstack partnership and integration will continue our commitment to advancing technology for our valued clients."

The Global Biogas Market Set To Reach A Value Of $102.7 Billion By 2027, Driven By Sustainability And Innovation

Retrieved on: 
Tuesday, September 19, 2023

LONDON, Sept. 19, 2023 /PRNewswire/ -- As per The Business Research Company's Biogas Global Market Report 2023, the global biogas market is on an upward trajectory, poised to grow from $71.59 billion in 2022 to $78.25 billion in 2023, demonstrating a robust Compound Annual Growth Rate (CAGR) of 9.3%. Projections indicate further expansion, reaching a substantial $102.7 billion by 2027, with a steady CAGR of 7.0%.

Key Points: 
  • The global biogas market is characterized by fragmentation, with numerous players contributing to its diversity.
  • Western Europe led the biogas market in 2022, accounting for 54.1% of the total market share.
  • The global biogas market is a dynamic and evolving landscape, driven by sustainability goals, innovation, and a growing commitment to cleaner energy solutions.
  • Biogas Global Market Report 2023 by The Business Research Company provides insights on the biogas market size, biogas market segments, biogas market trends, drivers and restraints, major competitors' market positioning, revenues and market shares.

The Global Biogas Market Set To Reach A Value Of $102.7 Billion By 2027, Driven By Sustainability And Innovation

Retrieved on: 
Tuesday, September 19, 2023

LONDON, Sept. 19, 2023 /PRNewswire/ -- As per The Business Research Company's Biogas Global Market Report 2023, the global biogas market is on an upward trajectory, poised to grow from $71.59 billion in 2022 to $78.25 billion in 2023, demonstrating a robust Compound Annual Growth Rate (CAGR) of 9.3%. Projections indicate further expansion, reaching a substantial $102.7 billion by 2027, with a steady CAGR of 7.0%.

Key Points: 
  • The global biogas market is characterized by fragmentation, with numerous players contributing to its diversity.
  • Western Europe led the biogas market in 2022, accounting for 54.1% of the total market share.
  • The global biogas market is a dynamic and evolving landscape, driven by sustainability goals, innovation, and a growing commitment to cleaner energy solutions.
  • Biogas Global Market Report 2023 by The Business Research Company provides insights on the biogas market size, biogas market segments, biogas market trends, drivers and restraints, major competitors' market positioning, revenues and market shares.

Inovalon Recognized as #1 Ranked Cloud-Based Data Platform Provider for Healthcare by Black Book Research

Retrieved on: 
Wednesday, September 6, 2023

BOWIE, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software solutions empowering data-driven healthcare, announced that following an assessment of 143 solution providers, Black Book Research has once again recognized Inovalon as the Top-Ranked Cloud-Based Data Platform for its robust data integration and predictive analytics that are part of its Converged SaaS suite of products.

Key Points: 
  • BOWIE, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software solutions empowering data-driven healthcare, announced that following an assessment of 143 solution providers, Black Book Research has once again recognized Inovalon as the Top-Ranked Cloud-Based Data Platform for its robust data integration and predictive analytics that are part of its Converged SaaS suite of products.
  • Overall, Inovalon was ranked #1, surpassing technology providers including ClearDATA, Amazon, Optum, Accenture, Salesforce, Redox, Microsoft, VMware, and IBM.
  • The Inovalon Payer Cloud is powered by the Inovalon ONE® Platform to transform traditional, siloed payer workflows into data-driven, converged workflows to support health plans in improving clinical quality metrics, risk score accuracy, value-based care performance, member and provider engagement, vaccine adherence, data intelligence, and many other use cases.
  • Black Book Research collected survey results on 18 key performance areas of operational excellence to rank vendors by electronic medical and health record product lines, with the data immediately subject to an internal and external audit to verify completeness and accuracy.

88% of U.S. Providers Plan to Increase Third-Party Technology Spending

Retrieved on: 
Wednesday, July 19, 2023

MADISON, Wis., July 19, 2023 /PRNewswire/ -- Many hospitals and health systems are still struggling to recover from one of the toughest financial years on record, yet 88% plan to increase their third-party technology investments in 2023-2024

Key Points: 
  • The uptick in providers' third-party technology spend is largely tied to their determined push for digital transformation, which the report identifies as providers' most important organizational goal for 2023-2024.
  • Many plan to use digital technologies to cut waste out of their operations (e.g., via automation), resulting in reduced costs and maximized efficiency.
  • While providers are turning to third-party solutions to help transform their operations, they're also acutely aware of their infrastructure limitations.
  • "For a long time, providers have thought about integration as connecting one technology to another," said Luke Bonney, CEO of Redox.

Redox Survey Reveals That Clinical Integration Challenges are Slowing Cloud Adoption for 97% of Provider Organizations

Retrieved on: 
Tuesday, June 13, 2023

The survey uncovered strategic cloud investment priorities for large healthcare organizations, including current and future use cases and desired business outcomes for cloud technology, as well as roadblocks to realizing those outcomes at scale.

Key Points: 
  • The survey uncovered strategic cloud investment priorities for large healthcare organizations, including current and future use cases and desired business outcomes for cloud technology, as well as roadblocks to realizing those outcomes at scale.
  • Findings are published in their new report " Uncovering hidden data roadblocks of cloud and AI adoption in healthcare ."
  • When evaluating future use cases, 97% of provider executives stated that ingesting real-time clinical data is crucial to their enablement – but only 3% haven't encountered any challenges when attempting to ingest clinical data into the cloud .
  • 86% of cloud integration projects take longer than 6 months to complete, while 34% take longer than 12 months.

Atlas Health Welcomes Executive Kevin Czarnecki as Chief Sales Officer

Retrieved on: 
Tuesday, May 16, 2023

SEATTLE, May 16, 2023 /PRNewswire/ -- Atlas Health, a market leader in philanthropic aid automation to improve access, affordability, outcomes and health equity for vulnerable populations, today announced the appointment of Kevin Czarnecki as Chief Sales Officer. Czarnecki will be responsible for driving Atlas Health's sales strategy as the company expands the reach of its philanthropic aid platform to healthcare organizations across the U.S.

Key Points: 
  • SEATTLE, May 16, 2023 /PRNewswire/ -- Atlas Health , a market leader in philanthropic aid automation to improve access, affordability, outcomes and health equity for vulnerable populations, today announced the appointment of Kevin Czarnecki as Chief Sales Officer.
  • Czarnecki will be responsible for driving Atlas Health's sales strategy as the company expands the reach of its philanthropic aid platform to healthcare organizations across the U.S.
    "As a distinguished industry veteran and sales expert, Kevin is the ideal addition to our rapidly growing executive team," said CEO Ethan Davidoff, Atlas Health.
  • Czarnecki is also a former executive vice president of sales at Redox, where he grew the company exponentially 450% in revenue.
  • "I am thrilled to be joining Atlas Health and see so much promise and potential in its purpose," Czarnecki said.